Cover Image
市場調查報告書

萎縮性胃炎:全球臨床實驗趨勢

Atrophic Gastritis Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 330940
出版日期 內容資訊 英文 46 Pages
訂單完成後即時交付
價格
Back to Top
萎縮性胃炎:全球臨床實驗趨勢 Atrophic Gastritis Global Clinical Trials Review, H1, 2017
出版日期: 2017年04月30日 內容資訊: 英文 46 Pages
簡介

本報告提供萎縮性胃炎相關臨床研究之最新趨勢分析,提供您各地區的臨床實驗數量,臨床實驗的各階段進展,受驗者採用狀況,有潛力的贊助商,各企業和研究機關上研究的進展,有潛力的藥劑比較等資訊。

簡介

  • 萎縮性胃炎
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要國家臨床實驗數量
    • 歐洲的主要國家臨床實驗數量

G7各國臨床實驗數量:腸胃疾病治療藥臨床實驗上萎縮性胃炎的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:腸胃疾病治療藥臨床實驗上萎縮性胃炎的比例

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標的達成情形

一定期間所採用的受驗者

贊助商類別的臨床實驗數量

有潛力的贊助商

萎縮性胃炎治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Trio Medicines Ltd.
    • Xinjiang Biochemical Pharmaceutical Co., Ltd.
  • 有代表性的研究機關·醫院臨床實驗概要
    • China Academy of Chinese Medical Sciences
    • Shenyang Military Command General Hospital
    • 東京大學醫學系附屬醫院
    • Chinese Academy of Sciences
    • Karolinska University Hospital
    • 衛生署
    • Shanghai University of Traditional Chinese Medicine
    • Sichuan University
    • 東北大學

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's clinical trial report, "Atrophic Gastritis Global Clinical Trials Review, H1, 2017" provides an overview of Atrophic Gastritis clinical trials scenario. This report provides top line data relating to the clinical trials on Atrophic Gastritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Countries Contributing to Clinical Trials in Central and South America 12
  • Clinical Trials by G7 Countries: Proportion of Atrophic Gastritis to Gastrointestinal Clinical Trials 13
  • Clinical Trials by Phase in G7 Countries 14
  • Clinical Trials in G7 Countries by Trial Status 15
  • Clinical Trials by E7 Countries: Proportion of Atrophic Gastritis to Gastrointestinal Clinical Trials 16
  • Clinical Trials by Phase in E7 Countries 17
  • Clinical Trials in E7 Countries by Trial Status 18
  • Clinical Trials by Phase 19
  • In Progress Trials by Phase 20
  • Clinical Trials by Trial Status 21
  • Clinical Trials by End Point Status 22
  • Subjects Recruited Over a Period of Time 23
  • Clinical Trials by Sponsor Type 24
  • Prominent Sponsors 25
  • Top Companies Participating in Atrophic Gastritis Therapeutics Clinical Trials 26
  • Prominent Drugs 27
  • Clinical Trial Profile Snapshots 28

Appendix 42

  • Abbreviations 42
  • Definitions 42
  • Research Methodology 43
  • Secondary Research 43
  • About GlobalData 44
  • Contact Us 44
  • Source 45

List of Tables

List of Tables

  • Atrophic Gastritis Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Atrophic Gastritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Atrophic Gastritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
  • Atrophic Gastritis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 9
  • Atrophic Gastritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
  • Atrophic Gastritis Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
  • Atrophic Gastritis Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 12
  • Proportion of Atrophic Gastritis to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 13
  • Atrophic Gastritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
  • Atrophic Gastritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
  • Proportion of Atrophic Gastritis to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 16
  • Atrophic Gastritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 17
  • Atrophic Gastritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Atrophic Gastritis Therapeutics, Global, Clinical Trials by Phase, 2017* 19
  • Atrophic Gastritis Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 20
  • Atrophic Gastritis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
  • Atrophic Gastritis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
  • Atrophic Gastritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
  • Atrophic Gastritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 24
  • Atrophic Gastritis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
  • Atrophic Gastritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26
  • Atrophic Gastritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27

List of Figures

List of Figures

  • Atrophic Gastritis Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Atrophic Gastritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Atrophic Gastritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
  • Atrophic Gastritis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 9
  • Atrophic Gastritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
  • Atrophic Gastritis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 12
  • Proportion of Atrophic Gastritis to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 13
  • Atrophic Gastritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
  • Atrophic Gastritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
  • Proportion of Atrophic Gastritis to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 16
  • Atrophic Gastritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 17
  • Atrophic Gastritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Atrophic Gastritis Therapeutics, Global, Clinical Trials by Phase (%), 2017* 19
  • Atrophic Gastritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 20
  • Atrophic Gastritis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
  • Atrophic Gastritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
  • Atrophic Gastritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 24
  • Atrophic Gastritis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
  • Atrophic Gastritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26
  • Atrophic Gastritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27
  • GlobalData Methodology 43
Back to Top